Overview

Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy

Status:
Recruiting
Trial end date:
2025-11-13
Target enrollment:
Participant gender:
Summary
Evaluate the safety, tolerability, and preliminary efficacy of GD-iEXo-002 nasal drops in the treatment of focal refractory epilepsy
Phase:
Early Phase 1
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborator:
Guidon Pharmaceutics Ltd.